Impact of Beta-Blockade on Cardiac Events in Patients with Chronic Severe Nonischemic Mitral Regurgitation Academic Article uri icon

Overview

MeSH Major

  • Bioprosthesis
  • Heart Valve Diseases
  • Heart Valve Prosthesis
  • Heart Valve Prosthesis Implantation

abstract

  • Beta-blockade appears to confer an increased risk of sudden cardiac death or indications for MVS among patients with chronic severe nonischemic MR. Randomized trials are needed to confirm these findings.

publication date

  • October 18, 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1159/000481250

PubMed ID

  • 29041004

Additional Document Info

start page

  • 1

end page

  • 6